MPE-282

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMPE-282
Drug Alias NameMPE-282
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet glycoprotein 4 modulators
TargetsPlatelet glycoprotein 4
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMperia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMperia Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A